Selectis Health, Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.7M | $7.3M | $9.7M | $10.8M | $10.4M | $10.5M | $10.4M | $10.0M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.1M | $2.1M | $2.1M | $2.1M | $2.2M | $2.4M | $2.3M | $2.4M |
| Operating Income | $-2.1M | $-1.3M | $-395.7K | $-297.0K | $-450.3K | $-421.7K | $-97.3K | $-1.2M |
| Operating Margin | -44.5% | -17.3% | -4.1% | -2.7% | -4.3% | -4.0% | -0.9% | -11.7% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $8.6M | $6.9M | — | — | $-308.0K | $-656.0K | — | — |
| Income Tax Expense | $471.4K | $409.7K | — | — | — | — | — | — |
| Net Income | $8.1M | $6.5M | $-804.1K | $752.4K | $-308.0K | $-656.0K | $-576.5K | $-1.6M |
| Net Margin | 171.9% | 89.5% | -8.3% | 6.9% | -3.0% | -6.3% | -5.5% | -16.0% |
| EPS (Basic) | $2.65 | $2.13 | $-0.26 | $0.24 | $-0.10 | $-0.22 | $-0.20 | $-0.52 |
| EPS (Diluted) | $2.35 | $1.90 | $-0.26 | $0.24 | $-0.10 | $-0.22 | $-0.20 | $-0.52 |
| Shares Outstanding (Basic) | 3.1M | 3.1M | 3.1M | 3.1M | 3.1M | 3.1M | 3.1M | 3.1M |
| Shares Outstanding (Diluted) | 3.5M | 3.4M | 3.1M | 3.1M | 3.1M | 3.1M | 3.1M | 3.1M |
| Dividends Per Share | — | — | — | — | — | — | — | — |